Skip to main content

Organon & Co / Organon Forei

Organon & Co is an American healthcare company focused on women's health, biosimilars, and established prescription pharmaceuticals. Spun off from Merck & Co, the company manufactures and markets reproductive health therapeutics, contraception solutions including Nexplanon, biosimilars, and mature brand cardiovascular and respiratory treatments. Main revenue drivers consist of global commercial sales of women's healthcare products, biosimilar pharmaceuticals, and established branded prescription drugs. Organon serves gynecologists, primary care physicians, hospital networks, prescription pharmacies, and patients globally. The company holds a market-leading global position in women's reproductive health and contraceptive therapies. Headquartered in Jersey City, New Jersey, Organon & Co is listed on the New York Stock Exchange.

8 of the funds FundTelligence covers report a position in Organon & Co / Organon Forei.

Sector
Health Care
Country
United States
Funds holding it
8

Funds holding Organon & Co / Organon Forei

Loading...